GlassScriptPhysician profile
Susan Brannon
NPI 1063548642
$1,470.10
in general payments reported to CMS, 2019-2025
18 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $103 · 2021: $363 · 2022: $300 · 2023: $174 · 2024: $284 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $455.44 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $262.75 | 2021-2024 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $140.14 | 2022 | |
| Ironshore Pharmaceuticals INC. | $114.47 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $92.20 | 2019-2025 | |
| Adlon Therapeutics L.P. | $83.66 | 2020-2021 | |
| Tris Pharma INC | $51.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $37.60 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $35.06 | 2020 | |
| Biomarin Pharmaceutical INC. | $34.06 | 2024 | Voxzogo 1.2mg |
| Genentech USA, INC. | $29.90 | 2019-2020 | |
| Seqirus USA INC | $29.35 | 2025 | Flucelvax |
| Biofire Diagnostics, LLC | $22.07 | 2020 | |
| Merck Sharp & Dohme LLC | $20.13 | 2022 | |
| Neos Therapeutics, LP | $18.48 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.81 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Brannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.